Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05289856
Title Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Johannes Gutenberg University Mainz
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Nationales Centrum für Tumorerkrankungen, Universitätsklinikum Heidelberg Heidelberg 69120 Germany Details
I. Medizinische Klinik und Poliklinik, Endokrinologie und Stoffwechselerkrankungen, Universitätsmedizin Mainz Mainz 55131 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field